Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

Added 49 days ago (19.10.2021)
Authors: Marcus Unterrainer; Julian Taugner; Lukas Käsmann; Amanda Tufman; Niels Reinmuth; Minglun Li; Lena M Mittlmeier; Peter Bartenstein; Wolfgang G Kunz; Jens Ricke; Claus Belka; Chukwuka Eze; Farkhad Manapov
Read article